Global Surgical Sealants and Adhesives Market
Dublin, June 09, 2022 (GLOBE NEWSWIRE) -- The "Surgical Sealants and Adhesives Market Size, Share & Trends Analysis Report by Type (Natural or Biological, Synthetic & Semi-synthetic), by Application (General Surgery, Cardiovascular), by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
The global surgical sealants and adhesives market size is expected to reach USD 5.4 billion by 2030. It is expected to expand at a CAGR of 11.4% from 2022 to 2030. Proper closure of injured tissues post-operation is a major step to restore tissue's structure and function.
Postoperative leakages occur in 3% to 15% of cases and are considered serious complications. They are responsible for one-third of postoperative deaths in patients. Surgical sealants and adhesives are designed to improve patient outcomes by reducing the prospect of postsurgical complications, such as leakages, thus resulting in improved patient outcomes through the prevention of leakage and a decrease in length of stay and mortality rates.
The rapid advancements in sealants and adhesives are major impact rendering drivers, and their usage in modern surgery to reduce anastomotic leakage has risen significantly. Surgical adhesive is expected to replace traditional surgical sealing agents such as sutures, wires, and staples.
These are time taking, can result in further tissue trauma, and are hard to use in some surgical locations. Surgical sealants overcome these issues and create immediate and proper sealing, compared to sutures and staples. The factors contributing to the growth of the market are the rising demand for surgical services worldwide and increasing concerns to reduce postoperative wound infections. Surgical procedures are increasing worldwide, with the WHO estimations projecting surgeries to account for approximately 235 million per year globally.
Surgical Sealants and Adhesives Market Report Highlights
North America held the largest revenue share in 2021 owing to the growing demand for high-quality healthcare in the region.
Asia Pacific is expected to observe lucrative growth over the forecast period due to the transformation of healthcare delivery systems into advanced value-based healthcare practices to establish a sustainable health system.
In the natural and biological adhesives and sealants type segment, the fibrin sealants segment accounted for the largest revenue share in 2021.
In the synthetic and semi-synthetic adhesives and sealants type segment, the cyanoacrylates segment is expected to register the fastest growth rate in the forecast period owing to its fast-drying properties, strong mechanical strength, and ease of adhesion.
Market participants combine a blend of both large public companies and more specialized small companies. These companies focus on only one segment or product. An example of such companies is Cohera Medical, Inc.
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Surgical Sealants and Adhesives Market Variables, Trends & Scope
3.1. Market Segmentation & Scopes
3.2. Surgical Sealants and Adhesives: Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Key Opportunities Prioritized
3.4. Surgical Sealants and Adhesives-SWOT Analysis, by Factor (Political & legal, economic and technological)
3.5. Industry Analysis-Porter's
3.6. Surgical Sealants and Adhesives Market: Market Position Analysis, 2015
Chapter 4. Surgical Sealants and Adhesives: Type Estimates & Trend Analysis
4.1. Surgical Sealants and Adhesives Market: Type Movement Analysis
4.1.1. Natural or biological adhesives and sealants
220.127.116.11. Natural or biological adhesives and sealants market, 2018-2030 (USD Million)
18.104.22.168.1. Fibrin Sealants
22.214.171.124.1.1. Fibrin sealants market, 2018-2030 (USD Million)
126.96.36.199.2. Collagen Based Adhesives
188.8.131.52.2.1. Collagen based adhesives market, 2018-2030 (USD Million)
184.108.40.206.3. Gelatin Based Adhesives
220.127.116.11.3.1. Gelatin based adhesives market, 2018-2030 (USD Million)
4.1.2. Synthetic and Semi-synthetic Adhesives and Sealants
18.104.22.168. Synthetic and semi-synthetic adhesives and sealants market, 2018-2030 (USD Million)
22.214.171.124.1.1. Cyanoacrylates market, 2018-2030 (USD Million)
126.96.36.199.2. Polymeric Hydrogels
188.8.131.52.2.1. Polymeric hydrogels market, 2018-2030 (USD Million)
184.108.40.206.3. Urethane Based Adhesives
220.127.116.11.3.1. Urethane based adhesives market, 2018-2030 (USD Million)
Chapter 5. Surgical Sealants and Adhesives: Application Estimates & Trend Analysis
5.1. Surgical Sealants and Adhesives Market: Application Movement Analysis
5.1.1. Central nervous system
18.104.22.168. Central nervous system market, 2018-2030 (USD Million)
22.214.171.124. Cardiovascular market, 2018-2030 (USD Million)
5.1.3. General surgery
126.96.36.199. General surgery market, 2018-2030 (USD Million)
188.8.131.52. Orthopedic market, 2018-2030 (USD Million)
184.108.40.206. Pulmonary market, 2018-2030 (USD Million)
220.127.116.11. Urology market, 2018-2030 (USD Million)
18.104.22.168. Ophthalmology market, 2018-2030 (USD Million)
22.214.171.124. Others market, 2018-2030 (USD Million)
Chapter 6. Surgical Sealants and Adhesives: Regional Estimates & Trend Analysis, by Type and Application
Chapter 7. Competitive Landscape
7.1. Company Profiles
7.1.1. Baxter International, Inc.
126.96.36.199. Company overview
188.8.131.52. Financial performance
184.108.40.206. Product benchmarking
220.127.116.11. Strategic initiatives
7.1.2. CryoLife, Inc.
18.104.22.168. Company overview
22.214.171.124. Financial performance
126.96.36.199. Product benchmarking
188.8.131.52. Strategic initiatives
7.1.3. C.R. Bard, Inc.
184.108.40.206. Company overview
220.127.116.11. Financial performance
18.104.22.168. Product benchmarking
22.214.171.124. Strategic initiatives
7.1.4. Medtronic PLC
126.96.36.199. Company overview
188.8.131.52. Financial performance
184.108.40.206. Product benchmarking
220.127.116.11. Strategic initiatives
7.1.5. B. Braun Melsungen AG
18.104.22.168. Company overview
22.214.171.124. Financial performance
126.96.36.199. Product benchmarking
188.8.131.52. Strategic initiatives
7.1.6. Cohera Medical, Inc.
184.108.40.206. Company overview
220.127.116.11. Financial performance
18.104.22.168. Product benchmarking
22.214.171.124. Strategic initiatives
7.1.7. Ethicon, Inc.
126.96.36.199. Company overview
188.8.131.52. Financial performance
184.108.40.206. Product benchmarking
220.127.116.11. Strategic initiatives
7.1.8. Mallinckrodt PLC
18.104.22.168. Company overview
22.214.171.124. Financial performance
126.96.36.199. Product benchmarking
188.8.131.52. Strategic initiatives
7.1.9. Cardinal Health
184.108.40.206. Company overview
220.127.116.11. Financial performance
18.104.22.168. Product benchmarking
22.214.171.124. Strategic initiatives
7.1.10. Integra LifeSciences Holdings Corporation
126.96.36.199. Company overview
188.8.131.52. Financial performance
184.108.40.206. Product benchmarking
220.127.116.11. Strategic initiatives
For more information about this report visit https://www.researchandmarkets.com/r/wq3vqx
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900